Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
09 April 2020 – Inova, Lyonbiopole, and Evaluate have joined forces to launch a unique virtual partnering event, backed by a consortium of biotech clusters and trade associations in the life sciences industry, to be held across the globe from 20 April to 6 May 2020.
Today’s COVID-19 crisis requires a previously unimaginable acceleration of output from the biopharmaceutical and life sciences industry. It raises the question about the ability to find the right partner in developing diagnostics, drug treatments and, ultimately, a COVID-19 vaccine. Beyond R&D – COVID-19 also raises a series of questions about the ability to handle the massive scale-up needed to deliver urgent solutions to protect health workers in the front line of the epidemic and patients alike.
The way forward requires an enormous leadership and collaboration effort within the life sciences industry to leave no stone unturned.
#PartneringAgainstCOVID19 is enabling small and big players worldwide to meet and match their skills and efforts against COVID-19.
The event is being made possible by Inova, which is leveraging its biopharma industry expertise, its leading digital networking platform and years of experience in organizing partnering events. Lyonbiopole and Evaluate will also support the event, leveraging their global life sciences networks and expertise.
Participation is free and open to any organization that provides products, knowledge, or technologies that can help in the effort to develop and produce testing, treatment and vaccine solutions to tackle the COVID-19 pandemic. Participants will be able to pursue:
“With today’s COVID-19 pandemic, and half of the globe staying at home, we need to take virtual partnering one step further and make it accessible to all. The team is proud to be part of this collective effort to continue to help biopharmaceutical companies accelerate their partnering efforts. Everyone's ultimate goal is to get solutions to patients”, says Gilles Toulemonde, CEO at Inova. “Partnering meetings usually take place face-to-face at large industry gatherings, but it’s now possible to #PartnerAtHome”.
“We’re delighted to be lead partner for this event”, adds Deborah Kobewka, CEO, Evaluate Ltd, a trusted provider of commercial intelligence to the pharma industry for over 20 years. “Today’s COVID-19 public health crisis requires a previously unimaginable acceleration of output from the biopharmaceutical and life sciences industry. We are now seeing a major demand for global partnerships and this event will be a key solution to help bring together the industry to collaborate in new and innovative ways”.
“We are very proud to be on board for the organization of this international partnering event against the current public health crisis”, says Florence Agostino-Etchetto, CEO of Lyonbiopole, a French Bio Cluster based in Auvergne-Rhône-Alpes. “Our region is historically strongly involved in the research and the fight against infectious diseases and the current crisis we are experiencing worldwide needs a global response. Partnership will be the keystone to provide effective solutions.”
The event is endorsed by a growing number of leading trade associations including the European Federation of Pharmaceutical and Associations (EFPIA), EuropaBio, EUCOPE as well as national associations and coalitions.
Event at a glance
What is a virtual Partnering Event?
A partnering event usually aims to facilitate interactions between attendees at big conferences in convention centres. Instead, we’re providing a safe, structured and easy-to-use online space for those working on solutions for COVID-19.
How does this work?
Follow the discussions on social media using #PartneringAgainstCOVID19 and #PartnerAtHome.
Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors.
Our Evaluate platform offers unique and dynamic insights into pharma asset risk and commercial potential alongside a seamless, comprehensive view of the pharmaceutical market landscape.
Evaluate Vantage – our award-winning, independent editorial team – provides thought-provoking news and insights into current and future industry developments.
Evaluate has been a partner to industry-leading organisations for over 20 years. For more information on how we give our clients the time and understanding to drive better decisions, visit www.evaluate.com.